Skip to navigation
ensure that the citizens of New Jersey receive the fullest
benefit of our nations fight against cancer through
the promotion and funding of research into the causes, prevention,
and treatment of cancer.
Together to Eradicate Cancer
its history, the New Jersey Commission on Cancer Research (NJCCR)
has united with members of the cancer community so that we might
work together to keep New Jersey on the cutting edge in the fight
1983, the New Jersey Legislature, guided by advocates across the
state, recognized the need to respond to the cancer epidemic.
With the passage of the Cancer Research Act (P.L.83, Ch.6), the
tobacco tax was increased in New Jersey to create an ongoing source
of funds to support the high human and economic costs of cancer.
Each year, this tax provides new dollars that are devoted to research
on the causes, prevention and treatment of cancer. Additional
funds come from taxpayer donations on the state income tax return
(Breast Cancer Research Fund and Prostate Cancer Research Fund),
the Conquer Cancer License Plate and from private donations. The
NJCCR administers these funds and supports research projects through
a competitive process for scientists across the state at a variety
of universities, research centers and other settings.
Early on in its development, the NJCCR recognized that the only
sure strategy for success in its mission was to invest in the
most talented people. With this in mind, the NJCCR has consistently
supported talented young researchers seeking to break into the
competitive world of cancer research, and senior investigators
embarking on new research directions. A National Institues of
Health system of scientific peer-review is used in making its
awards, which assures a rigorous and fair approach to all of its
date, the NJCCR has provided more than $23 million dollars for
over 500 research projects on cancer. This website presents the
NJCCR's recent activities, goals, progress and plans for the challenges
that lie ahead on the road to decreasing the human and economic
burden of cancer for the people of New Jersey.